Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Omega Funds
Entity

Omega Funds

Tracked across 1 events · 8 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026

Sentiment
55
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 55
Business
Vaderis $152M Series B and Phase 3 HEROIC
Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on rare vascular diseases, announced the closing of an oversubscribed $152 million Series B financing and the initiation of its global Phase 3 HEROIC study. The financing was…
Impact: Participated in the financing, gaining exposure to a promising rare disease asset. The investment is part of its healthcare portfolio strategy.
Aug 11, 2026 · 8 articles
Key Actions (1)
60 Omega Funds participated in financing Vaderis TherapeuticsVaderis $152M Series B and...
ERGEN INTELLIGENCE
Track Omega Funds live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.